fbpx
01 / 05
New Antivenom Raises Hopes Against Lethal Snakebites

Science | Accidents, Injuries & Poisonings

New Antivenom Raises Hopes Against Lethal Snakebites

“Researchers have discovered a potent antibody that can neutralize a key type of neurotoxin produced by four different deadly snake species from South Asia, Southeast Asia, and Africa…

The team is planning to follow the same discovery process with other classes of potent snake toxins. Their distant hope is to create a cocktail of antibodies that neutralizes the venoms from every dangerous snake on the planet.”

From Science.

NBC News | Vaccination

Chlamydia Vaccine Shows Promise in Early Trial

“An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet Infectious Diseases. 

There is currently no vaccine to protect against the sexually transmitted infection, which is the most common bacterial STI in the United States…

The phase 1 clinical trial, led by researchers in the United Kingdom and Denmark, found that the experimental vaccine was safe and induced an immune response.”

From NBC News.

The Daily Upside | Vaccination

Moderna Inches Nearer to Successful Cancer Vaccine

“Moderna has long touted that the mRNA vaccine technology it helped revolutionize during the global dash to create a coronavirus vaccine could be repurposed for a variety of medical uses. This vaccine, mRNA-4157, uses the method to train the immune system to identify and attack specific mutations in cancer cells.

The early-stage trial, conducted on patients already prescribed Merck’s Keytruda to treat certain types of head and neck cancer, produced some positive results — and hinted at an even brighter future for the vaccine.”

From The Daily Upside.

Nature | Health & Medical Care

“Mini Liver” Will Grow in Lymph Node in Bold New Trial

“A person has received an experimental treatment for the first time that, if successful, will lead them to grow an additional ‘miniature liver’. The procedure, developed by the biotechnology firm LyGenesis, marks the beginning of a clinical trial designed for people whose livers are failing, but who have not received an organ transplant.

The approach is unusual: researchers injected healthy liver cells from a donor into a lymph node in the upper abdomen of the person with liver failure. The idea is that in several months, the cells will multiply and take over the lymph node to form a structure that can perform the blood-filtering duties of the person’s failing liver.”

From Nature.